The winners of the 2014 BREAKTHROUGH PRIZE in fundamental physics and life sciences were announced Dec. 12 at the NASA Ames Center, in Mountain View, Calif.
It takes a few clicks to look up the name of a company that holds the “Abbreviated New Drug Application,” or ANDA, to make a generic drug. Alas, this information is of little value.
Death rates continued to decline for all cancers combined for men and women of all major racial and ethnic groups and for most major cancer sites, according to the Annual Report to the Nation on the Status of Cancer. Rates for both sexes combined decreased by 1.5 percent per year from 2001 through 2010.
ISSUE 1 – JAN. 3, 2014 PDF Who Makes This Drug? Secretive Contract Manufacturing Arrangements Complicate Solutions to Shortages of Generics By Rena M. Conti The closing of Ben Venue Laboratories, a company that produces a large share of generic drugs used by America’s oncologists, brings into focus a little-understood business practice that exacerbates the […]
THOMAS BURKE stepped down as executive vice president and physician-in-chief at MD Anderson Cancer Center to accept the new position of executive vice president of the MD Anderson Cancer Network.
Guest Editorial Why I Don't Want to Pay for Your Horoscope: Reflections on FDA Warning to 23andMeBy Jim Evans
What Is and Isn't a Crime in TexasCPRIT Official Indicted for Skipping Peer ReviewBy Paul Goldberg
ISSUE 46 – DEC. 13, 2013 PDF CPRIT Official Indicted for Skipping Peer ReviewBy Paul Goldberg A grand jury in Travis County, Texas, indicted a former official of the Cancer Prevention and Research Institute of Texas for bypassing peer review in awarding an $11 million grant to a Dallas-based company. Why I Don’t Want to […]
LENORA JOHNSON was named director of health education, communications, and science policy at the National Heart Lung and Blood Institute. Johnson will be leaving her job as director of the NCI Office of Communications and Education. Johnson will be leaving NCI Dec. 13.
